These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37055848)

  • 1. A thrombophilic allele of clotting Factor VII/VIIa promoting recurrent pulmonary emboli, clinical details, and a structural model of the altered protein: a case report.
    Newman K; Daldal F; Dancis A
    J Med Case Rep; 2023 Apr; 17(1):161. PubMed ID: 37055848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
    Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
    Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
    Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
    Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
    Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
    Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway.
    McVey JH
    Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modulation of factor VIIa by full-length tissue factor (TF
    Prasad R; Sen P
    J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tissue factor and factor VIIa in hemostasis.
    Mackman N
    Anesth Analg; 2009 May; 108(5):1447-52. PubMed ID: 19372318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric activation of coagulation factor VIIa.
    Persson E; Olsen OH
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3156-63. PubMed ID: 21622226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
    Frédérick R; Pochet L; Charlier C; Masereel B
    Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.
    Persson E; Kjalke M; Olsen OH
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13583-8. PubMed ID: 11698657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology of factor VIIa/tissue factor initiated coagulation.
    Vadivel K; Bajaj SP
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2476-94. PubMed ID: 22652793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency.
    Peyvandi F; De Cristofaro R; Garagiola I; Palla R; Akhavan S; Landolfi R; Mannucci PM
    Br J Haematol; 2004 Dec; 127(5):576-84. PubMed ID: 15566361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
    Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIIa-mediated tenase function on activated platelets under flow.
    Goel MS; Diamond SL
    J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.